KT
BIIB icon

Kanaly Trust’s Biogen BIIB Stock Holding History

Kanaly Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$20K Hold
70
– – ﹤0.01% 419
2016
Q3 		$22K Buy
70
+32
+84% +$9.48K ﹤0.01% 405
2016
Q2 		$9K Sell
38
-27
-42% -$7.12K ﹤0.01% 548
2016
Q1 		$17K Buy
65
+56
+622% +$14.8K ﹤0.01% 465
2015
Q4 		$3K Sell
9
-25
-74% -$7.18K ﹤0.01% 721
2015
Q3 		$10K Sell
34
-108
-76% -$35.7K ﹤0.01% 540
2015
Q2 		$57K Sell
142
-807
-85% -$324K 0.01% 297
2015
Q1 		$401K Buy
949
+904
+2,009% +$356K 0.08% 118
2014
Q4 		$15K Buy
45
+4
+10% +$1.29K ﹤0.01% 405
2014
Q3 		$14K Hold
41
– – ﹤0.01% 418
2014
Q2 		$13K Sell
41
-35
-46% -$10.5K ﹤0.01% 438
2014
Q1 		$23K Buy
+76
New +$24.1K ﹤0.01% 377

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kanaly Trust's BIIB Position: Q4 2016 in Review

Kanaly Trust held its Biogen (BIIB) position steady in Q4 2016 at 70 shares worth $20K. The position accounts for ﹤0.01% of the portfolio, ranked #419.

Kanaly Trust first reported a position in BIIB in Q1 2014 and has held it in 12 quarters since. The position peaked at $401K in Q1 2015. 1,025 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Kanaly Trust held 70 shares of Biogen worth $20K as of Q4 2016.
  • Kanaly Trust left its Biogen share count unchanged in Q4 2016.
  • Biogen made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #419 holding.
  • Kanaly Trust first reported a position in Biogen in Q1 2014 and has held it in 12 quarters since.
  • Kanaly Trust's Biogen position peaked at $401K in Q1 2015.
  • 1,025 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.